Literature DB >> 4329636

Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.

L B Elbert, M P Chumakov, G L Krutyanskaya, N M Ralph, A V Tyufanov, I S Sokolova, G A Alpatova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4329636     DOI： 10.1007/bf01254682

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  6 in total

1.  THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.

Authors:  V VONKA; Z JANDA; J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

2.  [Infection of tissue culture with viral ribonucleic acid as a method for the isolation of clones of poliomyelitis viruses with stable genetic characteristics].

Authors:  Iu Z GENDON; L S DISKINA; A T MARCHENKO
Journal:  Vopr Virusol       Date:  1961 Nov-Dec

3.  Study of the mutability of d lines of polioviruses.

Authors:  R DULBECCO; M VOGT
Journal:  Virology       Date:  1958-04       Impact factor: 3.616

4.  A type 3 attenuated poliovirus genetically stable after human intestinal passage.

Authors:  S A PLOTKIN; T W NORTON; B J COHEN; H KOPROWSKI
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

5.  Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.

Authors:  L B Elbert; M P Chumakov; G L Krutyanskaya; N M Ralph; A V Tyufanov
Journal:  Acta Virol       Date:  1968-05       Impact factor: 1.162

6.  A clinical trial of Glenn type 3 attenuated poliovirus vacine.

Authors:  J M Barnes; C S Heymann; N S Galbraith; G R O'Moore
Journal:  Arch Gesamte Virusforsch       Date:  1967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.